Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
HealthEquity Inc has a consensus price target of $111.24 based on the ratings of 17 analysts. The high is $130 issued by BTIG on November 14, 2024. The low is $77 issued by Goldman Sachs on October 21, 2022. The 3 most-recent analyst ratings were released by Barrington Research, Deutsche Bank, and Goldman Sachs on June 5, 2025, June 5, 2025, and June 4, 2025, respectively. With an average price target of $114.67 between Barrington Research, Deutsche Bank, and Goldman Sachs, there's an implied 3.15% upside for HealthEquity Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/05/2025 | Buy Now | 12.45% | Barrington Research | Alexander Paris86% | $112 → $125 | Maintains | Outperform | Get Alert |
06/05/2025 | Buy Now | 3.45% | Deutsche Bank | George Hill61% | $98 → $115 | Maintains | Buy | Get Alert |
06/04/2025 | Buy Now | -6.44% | Goldman Sachs | David Roman40% | $94 → $104 | Maintains | Neutral | Get Alert |
06/04/2025 | Buy Now | 5.25% | RBC Capital | Daniel Perlin58% | $112 → $117 | Maintains | Outperform | Get Alert |
06/04/2025 | Buy Now | 12.45% | B of A Securities | Allen Lutz55% | $110 → $125 | Maintains | Buy | Get Alert |
06/04/2025 | Buy Now | 5.25% | JMP Securities | Constantine Davides41% | $110 → $117 | Maintains | Market Outperform | Get Alert |
05/22/2025 | Buy Now | 0.76% | RBC Capital | Daniel Perlin58% | → $112 | Assumes | → Outperform | Get Alert |
04/16/2025 | Buy Now | -10.04% | Keybanc | Scott Schoenhaus48% | $110 → $100 | Maintains | Overweight | Get Alert |
04/11/2025 | Buy Now | 0.76% | Barrington Research | Alexander Paris86% | $112 → $112 | Maintains | Outperform | Get Alert |
03/27/2025 | Buy Now | -15.44% | Goldman Sachs | David Roman40% | $107 → $94 | Maintains | Neutral | Get Alert |
03/25/2025 | Buy Now | 3.45% | Raymond James | C. Gregory Peters79% | $120 → $115 | Upgrade | Outperform → Strong Buy | Get Alert |
03/24/2025 | Buy Now | -1.04% | Keybanc | Scott Schoenhaus48% | $120 → $110 | Maintains | Overweight | Get Alert |
03/19/2025 | Buy Now | 0.76% | Barrington Research | Alexander Paris86% | $112 → $112 | Maintains | Outperform | Get Alert |
03/14/2025 | Buy Now | 0.76% | Barrington Research | Alexander Paris86% | $112 → $112 | Maintains | Outperform | Get Alert |
02/26/2025 | Buy Now | 12.45% | Wells Fargo | Stan Berenshteyn47% | $110 → $125 | Maintains | Overweight | Get Alert |
02/25/2025 | Buy Now | 7.95% | Raymond James | C. Gregory Peters79% | $105 → $120 | Maintains | Outperform | Get Alert |
12/10/2024 | Buy Now | -3.74% | JMP Securities | Constantine Davides41% | $105 → $107 | Maintains | Market Outperform | Get Alert |
12/10/2024 | Buy Now | -5.54% | RBC Capital | Sean Dodge47% | $100 → $105 | Maintains | Outperform | Get Alert |
12/04/2024 | Buy Now | 13.35% | Mizuho | Steven Valiquette63% | → $126 | Initiates | → Outperform | Get Alert |
12/02/2024 | Buy Now | 7.95% | Barrington Research | Alexander Paris86% | $105 → $120 | Maintains | Outperform | Get Alert |
11/15/2024 | Buy Now | -2.84% | Goldman Sachs | David Roman40% | → $108 | Initiates | → Neutral | Get Alert |
11/14/2024 | Buy Now | 16.95% | BTIG | David Larsen47% | $110 → $130 | Maintains | Buy | Get Alert |
11/13/2024 | Buy Now | 7.95% | B of A Securities | Allen Lutz55% | $100 → $120 | Maintains | Buy | Get Alert |
09/20/2024 | Buy Now | -5.54% | Barrington Research | Alexander Paris86% | $105 → $105 | Maintains | Outperform | Get Alert |
09/04/2024 | Buy Now | -5.54% | Barrington Research | Alexander Paris86% | $105 → $105 | Maintains | Outperform | Get Alert |
09/04/2024 | Buy Now | -7.34% | Deutsche Bank | George Hill61% | $102 → $103 | Maintains | Buy | Get Alert |
09/04/2024 | Buy Now | -5.54% | JMP Securities | Constantine Davides41% | $105 → $105 | Reiterates | Market Outperform → Market Outperform | Get Alert |
09/04/2024 | Buy Now | -17.24% | RBC Capital | Sean Dodge47% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
09/04/2024 | Buy Now | -10.04% | B of A Securities | Allen Lutz55% | $105 → $100 | Maintains | Buy | Get Alert |
08/30/2024 | Buy Now | -5.54% | Barrington Research | Alexander Paris86% | $105 → $105 | Maintains | Outperform | Get Alert |
07/03/2024 | Buy Now | -5.54% | B of A Securities | Allen Lutz55% | $105 → $105 | Maintains | Buy | Get Alert |
06/20/2024 | Buy Now | -1.04% | Wells Fargo | Stan Berenshteyn47% | $107 → $110 | Maintains | Overweight | Get Alert |
06/07/2024 | Buy Now | -5.54% | Raymond James | C. Gregory Peters79% | $100 → $105 | Maintains | Outperform | Get Alert |
06/05/2024 | Buy Now | -10.04% | Keybanc | Scott Schoenhaus48% | $95 → $100 | Maintains | Overweight | Get Alert |
06/04/2024 | Buy Now | -3.74% | Wells Fargo | Stan Berenshteyn47% | $105 → $107 | Maintains | Overweight | Get Alert |
06/04/2024 | Buy Now | -5.54% | Barrington Research | Alexander Paris86% | $100 → $105 | Maintains | Outperform | Get Alert |
06/04/2024 | Buy Now | -17.24% | RBC Capital | Sean Dodge47% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
06/04/2024 | Buy Now | -5.54% | B of A Securities | Allen Lutz55% | $97 → $105 | Maintains | Buy | Get Alert |
06/04/2024 | Buy Now | -5.54% | JMP Securities | Constantine Davides41% | $101 → $105 | Maintains | Market Outperform | Get Alert |
06/04/2024 | Buy Now | -6.44% | Baird | Mark Marcon72% | $98 → $104 | Maintains | Outperform | Get Alert |
04/04/2024 | Buy Now | -9.14% | JMP Securities | Constantine Davides41% | → $101 | Initiates | → Market Outperform | Get Alert |
04/02/2024 | Buy Now | -2.84% | JP Morgan | Anne Samuel52% | $86 → $108 | Maintains | Overweight | Get Alert |
03/22/2024 | Buy Now | -14.54% | Keybanc | Scott Schoenhaus48% | $85 → $95 | Maintains | Overweight | Get Alert |
03/22/2024 | Buy Now | -10.04% | Barrington Research | Alexander Paris86% | → $100 | Maintains | Outperform | Get Alert |
03/20/2024 | Buy Now | -1.04% | BTIG | David Larsen47% | $100 → $110 | Maintains | Buy | Get Alert |
03/20/2024 | Buy Now | -17.24% | RBC Capital | Sean Dodge47% | $90 → $92 | Maintains | Outperform | Get Alert |
03/20/2024 | Buy Now | -12.74% | B of A Securities | Allen Lutz55% | $93 → $97 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | -19.04% | RBC Capital | Sean Dodge47% | $77 → $90 | Maintains | Outperform | Get Alert |
02/23/2024 | Buy Now | -6.44% | Barclays | — | $84 → $104 | Maintains | Overweight | Get Alert |
12/13/2023 | Buy Now | -14.54% | Raymond James | C. Gregory Peters79% | $90 → $95 | Maintains | Outperform | Get Alert |
12/06/2023 | Buy Now | -16.34% | Wells Fargo | Stan Berenshteyn47% | $89 → $93 | Maintains | Overweight | Get Alert |
12/04/2023 | Buy Now | -23.53% | Barrington Research | Alexander Paris86% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
12/01/2023 | Buy Now | -34.33% | JP Morgan | Anne Samuel52% | $81 → $73 | Maintains | Overweight | Get Alert |
09/21/2023 | Buy Now | -21.73% | Baird | Mark Marcon72% | $79 → $87 | Upgrade | Neutral → Outperform | Get Alert |
09/07/2023 | Buy Now | -35.23% | Deutsche Bank | George Hill61% | $71 → $72 | Maintains | Buy | Get Alert |
09/06/2023 | Buy Now | -23.53% | Barrington Research | Alexander Paris86% | $80 → $85 | Reiterates | Outperform → Outperform | Get Alert |
09/06/2023 | Buy Now | -30.73% | RBC Capital | Sean Dodge47% | $75 → $77 | Maintains | Outperform | Get Alert |
06/07/2023 | Buy Now | -36.13% | Deutsche Bank | George Hill61% | $69 → $71 | Maintains | Buy | Get Alert |
06/06/2023 | Buy Now | -32.53% | RBC Capital | Sean Dodge47% | → $75 | Reiterates | → Outperform | Get Alert |
06/01/2023 | Buy Now | -28.03% | Barrington Research | Alexander Paris86% | → $80 | Reiterates | Outperform → Outperform | Get Alert |
03/24/2023 | Buy Now | -37.93% | Deutsche Bank | George Hill61% | $72 → $69 | Maintains | Buy | Get Alert |
03/22/2023 | Buy Now | -28.03% | Barrington Research | Alexander Paris86% | → $80 | Reiterates | → Outperform | Get Alert |
03/22/2023 | Buy Now | -32.53% | RBC Capital | Sean Dodge47% | → $75 | Reiterates | → Outperform | Get Alert |
02/03/2023 | Buy Now | -19.94% | Wells Fargo | Stan Berenshteyn47% | $101 → $89 | Maintains | Overweight | Get Alert |
01/24/2023 | Buy Now | -35.23% | Deutsche Bank | George Hill61% | $68 → $72 | Maintains | Buy | Get Alert |
12/12/2022 | Buy Now | -23.53% | Raymond James | C. Gregory Peters79% | $75 → $85 | Maintains | Outperform | Get Alert |
12/07/2022 | Buy Now | -15.44% | Guggenheim | Sandy Draper73% | $89 → $94 | Maintains | Buy | Get Alert |
12/07/2022 | Buy Now | -9.14% | Wells Fargo | Stan Berenshteyn47% | $104 → $101 | Maintains | Overweight | Get Alert |
12/05/2022 | Buy Now | -32.53% | RBC Capital | Sean Dodge47% | $70 → $75 | Maintains | Outperform | Get Alert |
10/25/2022 | Buy Now | -6.44% | Wells Fargo | Stan Berenshteyn47% | $100 → $104 | Maintains | Overweight | Get Alert |
10/21/2022 | Buy Now | -30.73% | Goldman Sachs | Cindy Motz21% | $64 → $77 | Upgrade | Sell → Neutral | Get Alert |
09/16/2022 | Buy Now | -23.53% | Keybanc | Scott Schoenhaus48% | → $85 | Initiates | → Overweight | Get Alert |
09/13/2022 | Buy Now | -10.04% | Wells Fargo | Stan Berenshteyn47% | $95 → $100 | Maintains | Overweight | Get Alert |
09/12/2022 | Buy Now | -32.53% | Raymond James | C. Gregory Peters79% | $70 → $75 | Maintains | Outperform | Get Alert |
09/08/2022 | Buy Now | -38.83% | Deutsche Bank | George Hill61% | $67 → $68 | Maintains | Buy | Get Alert |
09/07/2022 | Buy Now | -39.73% | Baird | Mark Marcon72% | $47 → $67 | Maintains | Neutral | Get Alert |
07/12/2022 | Buy Now | -46.92% | Goldman Sachs | Cindy Motz21% | → $59 | Initiates | → Sell | Get Alert |
The latest price target for HealthEquity (NASDAQ:HQY) was reported by Barrington Research on June 5, 2025. The analyst firm set a price target for $125.00 expecting HQY to rise to within 12 months (a possible 12.45% upside). 32 analyst firms have reported ratings in the last year.
The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by Barrington Research, and HealthEquity maintained their outperform rating.
The last upgrade for HealthEquity Inc happened on March 25, 2025 when Raymond James raised their price target to $115. Raymond James previously had an outperform for HealthEquity Inc.
There is no last downgrade for HealthEquity.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $112.00 to $125.00. The current price HealthEquity (HQY) is trading at is $111.16, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.